Testing for NTRK Mutations in NSCLC – 2022 Program: Targeted Therapies Forum

Dive into the intricacies of NTRK mutations in non-small cell lung cancer with Dr. Nagashree Seetharamu in this enlightening session from the 2022 Targeted Therapies Forum. Uncover why testing for NTRK mutations is pivotal, and explore the various methodologies employed in the process.

Our heartfelt gratitude to our esteemed sponsors for championing this cause: #Novartis, #Janssen, #Blueprintmedicine, #TakedaOncology, #Astrazeneca, #LillyOncology, and #genentech.

Stay at the forefront of oncology research and breakthroughs. Visit http://cancerGRACE.org/. Engage with experts and a community driven by the same passion. Join the conversation at https://cancergrace.org/forum.